After a 14-week “TOP Health” technology sprint, four of 11 teams delivered digital tools that utilized federal open data or artificial intelligence (AI) to address Lyme and tick-borne diseases. These teams’ results were showcased over two days of events at the White House Eisenhower Executive Office Building and at the Census Bureau as part of “The Opportunity Project” (TOP) Demo Day 2019. NOTE: This blog emphasizes outcomes by the TOP Health Lyme teams.
Gil Alterovitz, PhD
When we began our 14-week tech health sprint in October 2018, we did not realize the profound lessons we would learn in just a few months. Together with federal agencies and private sector organizations, we demonstrated the power of applying artificial intelligence (AI) to open federal data. Through this collaborative process, we showed that federal data can be turned into products for real-world health applications with the potential to help millions of Americans have a better life.
This post was originally published on GSA.gov We have the best jobs in government, period. Each day we wake up empowered to solve critical issues facing public safety, national security, healthcare, and transportation. As Presidential Innovation Fellows (PIF), we are part of our nation’s Technology Transformation Services at the U.S. General Services Administration (GSA). We joined the federal government as entrepreneurs-in-residence to help federal agencies provide more accessible, efficient, and effective products and services to the American people and to tackle tough national problems.
Starting October 2018, Presidential Innovation Fellows (PIF) kicked-off and will lead a 14-week tech sprint with the U.S. Department of Health and Human Services (HHS) and other digital enthusiasts. The goal of this tech sprint is to transform federal open data from HHS, the U.S. Department of Veterans Affairs (VA), and other agencies into digital tools. Modeled after The Opportunity Project (TOP) at U.S. Department of Commerce, the TOP Health tech sprint is specifically designed to improve the patient experience, for example, by assisting in novel therapeutics accessibility and improving clinical trials.